MPPE1 and metabolic dysfunction-associated steatohepatitis: Still, in several reports, including our own, the ratio of hepatic cDC1 to cDC2 is decreased and the proportion of circulating blood cDC1 is also decreased in MASH patients [77, 78, 79].